Seminars in Hematology
Volume 41, Issue 4 , Pages 279-286 , October 2004

Gene therapy for the hemoglobin disorders

  • Derek A. Persons

      Affiliations

    • Department of Hematology/Oncology, Division of Experimental Hematology, St. Jude Children’s Research Hospital, Memphis, TN
    • Corresponding Author InformationAddress correspondence to Derek A. Persons, MD, PhD, Department of Hematology/Oncology, Division of Experimental Hematology, St. Jude Children’s Research Hospital, 332 N Lauderdale Dr, Memphis, TN 38105
    • ,
  • John F. Tisdale

      Affiliations

    • Molecular and Clinical Hematology Branch, National Institute of Diabetes and Digestive and Kidney Disorders, National Institutes of Health, Bethesda, MD

References 

  1. Lukens JN . The abnormal hemoglobins (General principles) . In:  Lee GF ,  Foerster JLJ editor. Wintrobe’s Clinical Hemtology . First ed.. Baltimore, MD: Williams & Wilkins; 1999;p. 1329–1345
  2. Bunn HF . Pathogenesis and treatment of sickle cell disease . N Engl J Med . 1997;337:762–769
  3. Weatherall DJ . The thalassemias . In:  Stamatoyannopoulos G ,  Majerus P ,  Perlmutter R ,  Varmus HE editor. The Molecular Basis for Blood Disorders . Philadelphia, PA: Saunders; 2001;p. 183–226
  4. Pootrakul P , Sirankapracha P , Hemsorach S , et al.   A correlation of erythrokinetics, ineffective erythropoiesis, and erythroid precursor apoptosis in thai patients with thalassemia . Blood . 2000;96:2606–2612
  5. Schrier SL . Pathophysiology of thalassemia . Curr Opin Hematol . 2002;9:123–126
  6. Hoppe CC , Walters MC . Bone marrow transplantation in sickle cell anemia . Curr Opin Oncol . 2001;13:85–90
  7. Williams DA , Lemischka IR , Nathan DG , et al.   Introduction of new genetic material into pluripotent haematopoietic stem cells of the mouse . Nature . 1984;310:476–480
  8. Dick JE , Magli MC , Huszar D , et al.   Introduction of a selectable gene into primitive stem cells capable of long-term reconstitution of the hemopoietic system of W/Wv mice . Cell . 1985;42:71–79
  9. Dunbar CE , Cottler-Fox M , O’Shaughnessy JA , et al.   Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation . Blood . 1995;85:3048–3057
  10. Hanania EG , Giles RE , Kavanagh J , et al.   Results of MDR-1 vector modification trial indicate that granulocyte/macrophage colony-forming unit cells do not contribute to posttransplant hematopoietic recovery following intensive systemic therapy . Proc Natl Acad Sci USA . 1996;93:15346–15351
  11. Orlic D , Girard LJ , Jordan CT , et al.   The level of mRNA encoding the amphotropic retrovirus receptor in mouse and human hematopoietic stem cells is low and correlates with the efficiency of retrovirus transduction . Proc Natl Acad Sci USA . 1996;93:11097–11102
  12. Bukrinsky MI , Haggerty S , Dempsey MP , et al.   A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells . Nature . 1993;365:666–669
  13. Zack JA , Haislip AM , Krogstad P , et al.   Incompletely reverse-transcribed human immunodeficiency virus type 1 genomes in quiescent cells can function as intermediates in the retroviral life cycle . J Virol . 1992;66:1717–1725
  14. Miyoshi H , Smith KA , Mosier DE , et al.   Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors . Science . 1999;283:682–686
  15. Guenechea G , Gan OI , Inamitsu T , et al.   Transduction of human CD34+ . Mol Ther . 2000;1:566–573
  16. Hanawa H , Kelly PF , Nathwani AC , et al.   Comparison of various envelope proteins for their ability to pseudotype lentiviral vectors and transduce primitive hematopoietic cells from human blood . Mol Ther . 2002;5:242–251
  17. An DS , Wersto RP , Agricola BA , et al.   Marking and gene expression by a lentivirus vector in transplanted human and nonhuman primate CD34(+) cells . J Virol . 2000;74:1286–1295
  18. An DS , Kung SK , Bonifacino A , et al.   Lentivirus vector-mediated hematopoietic stem cell gene transfer of common gamma-chain cytokine receptor in rhesus macaques . J Virol . 2001;75:3547–3555
  19. Horn PA , Morris JC , Bukovsky AA , et al.   Lentivirus-mediated gene transfer into hematopoietic repopulating cells in baboons . Gene Ther . 2002;9:1464–1471
  20. Cowan S , Hatziioannou T , Cunningham T , et al.   Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism . Proc Natl Acad Sci USA . 2002;99:11914–11919
  21. Besnier C , Takeuchi Y , Towers G . Restriction of lentivirus in monkeys . Proc Natl Acad Sci USA . 2002;99:11920–11925
  22. Hanawa H , Hematti P , Keyvanfar K , Krouse A , Donahue RE , Kepes S . Efficient gene transfer into rhesus repopulating hematopoietic stem cells using a simian immunodeficiency virus-based lentiviral vector system . Blood . 2004;103:4062–4069
  23. Kootstra NA , Munk C , Tonnu N , et al.   Abrogation of postentry restriction of HIV-1-based lentiviral vector transduction in simian cells . Proc Natl Acad Sci USA . 2003;100:1298–1303
  24. Karlsson S , Bodine DM , Perry L , et al.   Expression of the human beta-globin gene following retroviral-mediated transfer into multipotential hematopoietic progenitors of mice . Proc Natl Acad Sci USA . 1988;85:6062–6066
  25. Dzierzak EA , Papayannopoulou T , Mulligan RC . Lineage-specific expression of a human beta-globin gene in murine bone marrow transplant recipients reconstituted with retrovirus-transduced stem cells . Nature . 1988;331:35–41
  26. Tuan D , Solomon W , Li Q , et al.   The “beta-like-globin” gene domain in human erythroid cells . Proc Natl Acad Sci USA . 1985;82:6384–6388
  27. Talbot D , Collis P , Antoniou M , et al.   A dominant control region from the human beta-globin locus conferring integration site-independent gene expression . Nature . 1989;338:352–355
  28. Grosveld F , van Assendelft GB , Greaves DR , et al.   Position-independent, high-level expression of the human beta-globin gene in transgenic mice . Cell . 1987;51:975–985
  29. Persons DA , Nienhuis AW . Gene therapy for the hemoglobin disorders (Past, present, and future) . Proc Natl Acad Sci USA . 2000;97:5022–5024
  30. Sadelain M , Wang CH , Antoniou M , et al.   Generation of a high-titer retroviral vector capable of expressing high levels of the human beta-globin gene . Proc Natl Acad Sci USA . 1995;92:6728–6732
  31. Leboulch P , Huang GM , Humphries RK , et al.   Mutagenesis of retroviral vectors transducing human beta-globin gene and beta-globin locus control region derivatives results in stable transmission of an active transcriptional structure . EMBO J . 1994;13:3065–3076
  32. Raftopoulos H , Ward M , Leboulch P , et al.   Long-term transfer and expression of the human beta-globin gene in a mouse transplant model . Blood . 1997;90:3414–3422
  33. Kalberer CP , Pawliuk R , Imren S , et al.   Preselection of retrovirally transduced bone marrow avoids subsequent stem cell gene silencing and age-dependent extinction of expression of human beta-globin in engrafted mice . Proc Natl Acad Sci USA . 2000;97:5411–5415
  34. Rivella S , Sadelain M . Genetic treatment of severe hemoglobinopathies (The combat against transgene variegation and transgene silencing) . Semin Hematol . 1998;35:112–125
  35. Grande A , Piovani B , Aiuti A , et al.   Transcriptional targeting of retroviral vectors to the erythroblastic progeny of transduced hematopoietic stem cells . Blood . 1999;93:3276–3285
  36. Moreau-Gaudry F , Xia P , Jiang G , et al.   High-level erythroid-specific gene expression in primary human and murine hematopoietic cells with self-inactivating lentiviral vectors . Blood . 2001;98:2664–2672
  37. Sabatino DE , Seidel NE , Aviles-Mendoza GJ , et al.   Long-term expression of gamma-globin mRNA in mouse erythrocytes from retrovirus vectors containing the human gamma-globin gene fused to the ankyrin-1 promoter . Proc Natl Acad Sci USA . 2000;97:13294–13299
  38. Emery DW , Yannaki E , Tubb J , et al.   Development of virus vectors for gene therapy of beta chain hemoglobinopathies (Flanking with a chromatin insulator reduces gamma-globin gene silencing in vivo) . Blood . 2002;100:2012–2019
  39. May C , Rivella S , Callegari J , et al.   Therapeutic haemoglobin synthesis in beta-thalassaemic mice expressing lentivirus-encoded human beta-globin . Nature . 2000;406:82–86
  40. Pawliuk R , Westerman KA , Fabry ME , et al.   Correction of sickle cell disease in transgenic mouse models by gene therapy . Science . 2001;294:2368–2371
  41. Persons DA , Hargrove PW , Allay ER , et al.   The degree of phenotypic correction of murine beta-thalassemia intermedia following lentiviral-mediated transfer of a human gamma-globin gene is influenced by chromosomal position effects and vector copy number . Blood . 2003;101:2175–2183
  42. May C , Rivella S , Chadburn A , et al.   Successful treatment of murine beta-thalassemia intermedia by transfer of the human beta-globin gene . Blood . 2002;99:1902–1908
  43. Levasseur DN , Ryan TM , Pawlik KM , et al.   Correction of a mouse model of sickle cell disease (lentiviral/antisickling beta-globin gene transduction of unmobilized, purified hematopoietic stem cells) . Blood . 2003;102:4312–4319
  44. Imren S , Payen E , Westerman KA , et al.   Permanent and panerythroid correction of murine beta thalassemia by multiple lentiviral integration in hematopoietic stem cells . Proc Natl Acad Sci USA . 2002;99:14380–14385
  45. Bunn HF . Induction of fetal hemoglobin in sickle cell disease . Blood . 1999;93:1787–1789
  46. Persons DA , Allay ER , Sabatino DE , et al.   Functional requirements for phenotypic correction of murine beta-thalassemia (Implications for human gene therapy) . Blood . 2001;97:3275–3282
  47. Kean LS , Manci EA , Perry J , et al.   Chimerism and cure (Hematologic and pathologic correction of murine sickle cell disease) . Blood . 2003;102:4582–4593
  48. Rivella S , May C , Chadburn A , et al.   A novel murine model of Cooley anemia and its rescue by lentiviral-mediated human beta-globin gene transfer . Blood . 2003;101:2932–2939
  49. Molete JM , Petrykowska H , Bouhassira EE , et al.   Sequences flanking hypersensitive sites of the beta-globin locus control region are required for synergistic enhancement . Mol Cell Biol . 2001;21:2969–2980
  50. Hanawa H , Hargrove PW , Kepes S , Nienhuis AW , Persons DA . Extended γ-globin locus control region elements promote consistent therapeutic expression of a γ-globin lentiviral vector in murine β-thalassemia . Blood . First Edition. 2004; Paper, prepublished online June 15, DOI 10.1182/blood-2004–03–0863
  51. Burgess-Beusse B , Farrell C , Gaszner M , et al.   The insulation of genes from external enhancers and silencing chromatin . Proc Natl Acad Sci USA . 2002;99(suppl 4):16433–16437
  52. Rivella S , Callegari JA , May C , et al.   The cHS4 insulator increases the probability of retroviral expression at random chromosomal integration sites . J Virol . 2000;74:4679–4687
  53. Cavazzana-Calvo M , Hacein-Bey S , de Saint BG , et al.   Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease . Science . 2000;288:669–672
  54. Aiuti A , Slavin S , Aker M , et al.   Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning . Science . 2002;296:2410–2413
  55. Stewart FM , Crittenden RB , Lowry PA , et al.   Long-term engraftment of normal and post-5-fluorouracil murine marrow into normal nonmyeloablated mice . Blood . 1993;81:2566–2571
  56. Ramshaw HS , Rao SS , Crittenden RB , et al.   Engraftment of bone marrow cells into normal unprepared hosts (Effects of 5-fluorouracil and cell cycle status) . Blood . 1995;86:924–929
  57. Rao SS , Peters SO , Crittenden RB , et al.   Stem cell transplantation in the normal nonmyeloablated host (relationship between cell dose, schedule, and engraftment) . Exp Hematol . 1997;25:114–121
  58. Mardiney M , Malech HL . Enhanced engraftment of hematopoietic progenitor cells in mice treated with granulocyte colony-stimulating factor before low-dose irradiation (Implications for gene therapy) . Blood . 1996;87:4049–4056
  59. Giri N , Kaushiva A , Wu T , et al.   The effects of SCF/G-CSF prestimulation on radiation sensitivity and engraftment in nonmyeloablated murine hosts . Exp Hematol . 2001;29:779–785
  60. Huhn RD , Tisdale JF , Agricola B , et al.   Retroviral marking and transplantation of rhesus hematopoietic cells by nonmyeloablative conditioning . Hum Gene Ther . 1999;10:1783–1790
  61. Rosenzweig M , MacVittie TJ , Harper D , et al.   Efficient and durable gene marking of hematopoietic progenitor cells in nonhuman primates after nonablative conditioning . Blood . 1999;94:2271–2286
  62. Kang EM , Hanazano Y , Frare P , et al.   Persistent low-level engraftment of rhesus peripheral blood progenitor cells transduced with the Fanconi anemia C gene after conditioning with low-dose irradiation . Mol Ther . 2001;3:911–919
  63. Heim DA , Hanazono Y , Giri N , et al.   Introduction of a xenogeneic gene via hematopoietic stem cells leads to specific tolerance in a rhesus monkey model . Mol Ther . 2000;1:533–544
  64. Shull R , Lu X , Dube I , et al.   Humoral immune response limits gene therapy in canine MPS I . Blood . 1996;88:377–379
  65. Persons DA , Nienhuis AW . In vivo selection to improve gene therapy of hematopoietic disorders . Curr Opin Mol Ther . 2002;4:491–498
  66. Nesci S , Manna M , Andreani M , et al.   Mixed chimerism in thalassemic patients after bone marrow transplantation . Bone Marrow Transplant . 1992;10:143–146
  67. Bernaudin F , Souillet G , Vannier JP , et al.   Bone marrow transplantation (BMT) in 14 children with severe sickle cell disease (SCD) (The French experience) . GEGMO. Bone Marrow Transplant . 1993;12(suppl 1):118–121
  68. Andreani M , Nesci S , Lucarelli G , et al.   Long-term survival of ex-thalassemic patients with persistent mixed chimerism after bone marrow transplantation . Bone Marrow Transplant . 2000;25:401–404
  69. Sorrentino BP . Gene therapy to protect haematopoietic cells from cytotoxic cancer drugs . Nat Rev Cancer . 2002;2:431–441
  70. Davis BM , Koc ON , Gerson SL . Limiting numbers of G156A O(6)-methylguanine-DNA methyltransferase-transduced marrow progenitors repopulate nonmyeloablated mice after drug selection . Blood . 2000;95:3078–3084
  71. Ragg S , Xu-Welliver M , Bailey J , et al.   Direct reversal of DNA damage by mutant methyltransferase protein protects mice against dose-intensified chemotherapy and leads to in vivo selection of hematopoietic stem cells . Cancer Res . 2000;60:5187–5195
  72. Sawai N , Zhou S , Vanin EF , et al.   Protection and in vivo selection of hematopoietic stem cells using temozolomide, O6-benzylguanine, and an alkyltransferase-expressing retroviral vector . Mol Ther . 2001;3:78–87
  73. Jin L , Zeng H , Chien S , et al.   In vivo selection using a cell-growth switch . Nat Genet . 2000;26:64–66
  74. Thorsteinsdottir U , Sauvageau G , Humphries RK . Enhanced in vivo regenerative potential of HOXB4-transduced hematopoietic stem cells with regulation of their pool size . Blood . 1999;94:2605–2612
  75. Persons DA , Allay ER , Sawai N , et al.   Successful treatment of murine {beta}-thalassemia using in vivo selection of genetically modified, drug-resistant hematopoietic stem cells . Blood . 2003;102:506–513
  76. Neff T , Horn PA , Valli VE , et al.   Pharmacologically regulated in vivo selection in a large animal . Blood . 2002;100:2026–2031
  77. Hanazono Y , Nagashima T , Takatoku M , et al.   In vivo selective expansion of gene-modified hematopoietic cells in a nonhuman primate model . Gene Ther . 2002;9:1055–1064
  78. Nagashima T , Ueda Y , Hanazono Y , et al.   In vivo expansion of gene-modified hematopoietic cells by a novel selective amplifier gene utilizing the erythropoietin receptor as a molecular switch . J Gene Med . 2004;6:22–31
  79. Wu T , Kim HJ , Sellers SE , et al.   Prolonged high-level detection of retrovirally marked hematopoietic cells in nonhuman primates after transduction of CD34+ progenitors using clinically feasible methods . Mol Ther . 2000;1:285–293
  80. Takatoku M , Sellers S , Agricola BA , et al.   Avoidance of stimulation improves engraftment of cultured and retrovirally transduced hematopoietic cells in primates . J Clin Invest . 2001;108:447–455
  81. Horn PA , Topp MS , Morris JC , et al.   Highly efficient gene transfer into baboon marrow repopulating cells using GALV-pseudotype oncoretroviral vectors produced by human packaging cells . Blood . 2002;100:3960–3967
  82. Kiem HP , Andrews RG , Morris J , et al.   Improved gene transfer into baboon marrow repopulating cells using recombinant human fibronectin fragment CH-296 in combination with interleukin-6, stem cell factor, FLT-3 ligand, and megakaryocyte growth and development factor . Blood . 1998;92:1878–1886
  83. Pauling L , Itano HA , Singer SJ , et al.   Sickle cell anemia, a molecular disease . Science . 1949;110:543–548

 Supported in part by the National Heart, Lung, and Blood Institute (NHLBI) Grants No. KO8 HL04205 and RO1 HL70705, NHLBI Comprehensive Sickle Cell Center Grant No. U54 HL70590, NHLBI Program Project Grant No. PO1 HL53749, Cancer Center Support (CORE) Grant No. CA-21765, and the American Lebanese Syrian Associated Charities.

PII: S0037-1963(04)00127-1

doi: 10.1053/j.seminhematol.2004.07.004

Seminars in Hematology
Volume 41, Issue 4 , Pages 279-286 , October 2004

Article Tools

* Image Usage & Resolution